<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations and diagnosis of IgG4-related disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations and diagnosis of IgG4-related disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations and diagnosis of IgG4-related disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Haralampos M Moutsopoulos, MD, FACP, FRCP, Master ACR</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George E Fragoulis, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John H Stone, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter H Schur, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Philip Seo, MD, MHS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 29, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2307580520"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory condition that is capable of affecting multiple organs [<a href="#rid1">1-3</a>].</p><p>Organs affected by IgG4-RD share pathologic, serologic, and clinical features. Before its recognition as a unified disease in the early 2000s, the diseases discussed in this topic had been presumed to be unrelated, single-organ disorders [<a href="#rid4">4-6</a>].</p><p>The clinical features, diagnosis, and differential diagnosis of IgG4-RD are presented here. The treatment and prognosis of IgG4-RD are described separately. (See  <a class="medical medical_review" href="/z/d/html/121219.html" rel="external">"Treatment and prognosis of IgG4-related disease"</a>.)</p><p>Type 1 autoimmune pancreatitis (AIP; IgG4-related pancreatitis) and IgG4-related sclerosing cholangitis are also discussed in more detail elsewhere (see  <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">"Autoimmune pancreatitis: Clinical manifestations and diagnosis"</a>), as are several of the other conditions associated with this disorder. (See appropriate topic reviews).</p><p class="headingAnchor" id="H107559437"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>In a 2023 study, the overall incidence of IgG4-RD was estimated to be 0.78 to 1.39 per 100,000 person-years [<a href="#rid7">7</a>]. The epidemiology of specific forms of IgG4-RD is discussed below.</p><p class="headingAnchor" id="H2007858330"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H2175368223"><span class="h2">Spectrum of disease</span><span class="headingEndMark"> — </span>Immunoglobulin G4-related disease (IgG4-RD) can involve one or multiple organs, and manifestations of this disease have been demonstrated in nearly every organ system [<a href="#rid1">1,2,8,9</a>]. Patients often present with subacute development of a mass in the affected organ or diffuse enlargement of an organ [<a href="#rid1">1,5,10</a>].</p><p>Patients often feel well at the time of diagnosis. Lymphadenopathy is common, but patients are generally afebrile [<a href="#rid11">11</a>]. However, symptoms of asthma or allergy are present in approximately 40 percent of patients. Additionally, patients with multiorgan disease often lose substantial amounts of weight (eg, 20 to 30 pounds), which may be due to IgG4-related autoimmune pancreatitis (AIP). (See <a class="local">'Autoimmune pancreatitis'</a> below.)</p><p>IgG4-RD is often recognized incidentally based on a radiologic finding or histopathologic examination of a tissue specimen. Imaging studies (eg, computed tomography [CT], magnetic resonance imaging [MRI], positron emission tomography [PET]) may demonstrate diffuse or focal organ lesions (usually a mass or swelling).</p><p>Clinicians should be alert to the possibility that IgG4-RD can mimic some autoimmune rheumatic diseases such as Sjögren's disease, systemic lupus erythematosus, and granulomatosis with polyangiitis (GPA), as well as a number of other conditions. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H1045873420"><span class="h2">Autoimmune pancreatitis</span><span class="headingEndMark"> — </span>The salient issues regarding IgG4-related AIP are briefly outlined here. An overview of AIP is provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">"Autoimmune pancreatitis: Clinical manifestations and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nomenclature</strong> – Two types of AIP have been defined. Type 1 AIP (which is associated with IgG4-RD) is also called lymphoplasmacytic sclerosing pancreatitis [<a href="#rid12">12</a>]. Type 2 AIP (which is not associated with IgG4-RD) is sometimes called either idiopathic duct-centric chronic pancreatitis (IDCP) or granulocyte-positive epithelial pancreatitis [<a href="#rid13">13,14</a>]. Some experts have proposed that the term AIP should be reserved for type 1 AIP and that the term IDCP be used for type 2 AIP [<a href="#rid14">14,15</a>]. AIP is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">"Autoimmune pancreatitis: Clinical manifestations and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – AIP has been estimated to account for 2 percent of patients with chronic pancreatitis [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">The prevalence of type 1 AIP in Japan has been estimated to be 0.82 per 100,000 persons. However, this is likely to be an underestimate because the study was performed when IgG4-RD was a newly described condition [<a href="#rid16">16,17</a>].</p><p></p><p class="bulletIndent1">Type 2 AIP (which is not associated with IgG4-RD) appears to be much less common than type 1 AIP and is sometimes associated with inflammatory bowel disease [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Type 1 AIP often presents as a pancreatic mass or as painless obstructive jaundice and can be mistaken for pancreatic cancer. Patients with type 1 AIP may exhibit acute, recurrent, or chronic pancreatitis. Complications of AIP frequently include glucose intolerance or frank type 2 diabetes mellitus and, more frequently, exocrine pancreatic insufficiency.</p><p></p><p class="bulletIndent1">Most patients with type 1 AIP have another concomitant IgG4-related condition, such as IgG4-related sclerosing cholangitis, lymphadenopathy, IgG4-related tubulointerstitial nephritis, IgG4-related salivary gland involvement, or other disease manifestations. These disease manifestations are discussed in greater detail below.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging features</strong> – Radiologic features of AIP include diffuse enlargement of the pancreas, leading to the descriptor "sausage-shaped" pancreas, and a halo of edema surrounding the organ. Both of these features are appreciated most readily on abdominal CT scanning. The radiologic findings in types 1 and 2 AIP are similar, and the two entities cannot be distinguished on the basis of their imaging features. Other imaging features of AIP are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5657.html" rel="external">"Autoimmune pancreatitis: Clinical manifestations and diagnosis", section on 'Imaging findings'</a>.)</p><p></p><p class="headingAnchor" id="H928935913"><span class="h2">IgG4-related sclerosing cholangitis</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – IgG4-related sclerosing cholangitis is present in more than 70 percent of patients with IgG4-related AIP but sometimes occurs as isolated cholangitis in the absence of pancreatic disease [<a href="#rid5">5</a>]. (See <a class="local">'Autoimmune pancreatitis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – IgG4-related sclerosing cholangitis and primary sclerosing cholangitis have similar clinical presentations, which include abdominal discomfort, diarrhea, malaise, jaundice, and pruritus. However, many patients with IgG4-related sclerosing cholangitis are asymptomatic at the time of diagnosis.</p><p></p><p class="bulletIndent1">Patients with IgG4-related sclerosing cholangitis often have extrabiliary manifestations of IgG4-RD [<a href="#rid19">19,20</a>]. The combination of biliary tract and pancreatic disease is nearly diagnostic of IgG4-RD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging features</strong> – Biliary tract imaging of IgG4-related sclerosing cholangitis is characterized by diffuse or segmental narrowing of the intrahepatic and/or extrahepatic bile duct, associated with thickening of the bile duct wall, but these features may not be present in all cases [<a href="#rid21">21</a>].</p><p></p><p class="headingAnchor" id="H3804944035"><span class="h2">Lymphadenopathy</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Asymptomatic IgG4-related lymphadenopathy is common, occurring in 41 to 80 percent of patients with AIP [<a href="#rid22">22,23</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The lymphadenopathy is generally non-tender and the nodes themselves are rubbery rather than hard. The lymphadenopathy is often asymptomatic at the time of diagnosis. However, it may also present with symptoms due to impingement on other organs. The mediastinal, hilar, intraabdominal, and axillary lymph nodes are most commonly involved; multiple groups of lymph nodes are often involved simultaneously [<a href="#rid24">24</a>]. Individual nodes are typically no more than 2 centimeters in diameter but may range up to 5 centimeters [<a href="#rid25">25</a>]. IgG4-related lymphadenopathy may be the initial or only manifestation of IgG4-RD in a given patient [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging features</strong> – Multiple imaging studies (eg, ultrasound, CT, MRI, gallium-67) may be used to detect IgG4 lymphadenopathy. However, IgG4-related lymphadenopathy may not enhance, and the radiologic characteristics are not specific for this diagnosis.</p><p></p><p class="headingAnchor" id="H3797233426"><span class="h2">Salivary gland involvement</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nomenclature</strong> – Various combinations of the salivary glands can be involved in IgG4-RD. Mikulicz disease refers to the simultaneous enlargement of the lacrimal, parotid, and submandibular glands. Küttner tumor refers to bilateral sclerosing sialadenitis of the submandibular glands [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Nearly 40 percent of patients with IgG4-related pancreatitis also have salivary or lacrimal gland involvement. Unlike AIP and other forms of IgG4-RD, IgG4-RD of the salivary glands affects males and females equally [<a href="#rid23">23,27</a>] </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Major salivary gland (parotid or submandibular) involvement is a common feature of IgG4-RD.</p><p></p><p class="bulletIndent1">Parotiditis and submandibular sialadenitis present with bilaterally symmetric, tender masses between the ear and jaw (ie, parotid gland) or beneath the jaw (ie, submandibular gland). The sublingual glands may also be affected, although their enlargement is often more difficult to detect on physical examination.</p><p></p><p class="bulletIndent1">AIP is detected in approximately 17 percent of patients presenting with IgG4-related sialadenitis [<a href="#rid22">22,27</a>]. Sialadenitis often presents prior to AIP in patients who develop both conditions [<a href="#rid28">28</a>]. (See <a class="local">'IgG4-related sclerosing cholangitis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging features</strong> – Ultrasound may identify abnormalities associated with IgG4 salivary gland disease, such as masses and decreased echogenicity [<a href="#rid29">29</a>]. Other imaging studies (eg, CT, MRI) may be useful for identifying salivary gland enlargement, which may not enhance. MRI of an involved gland may be hypointense on T2 imaging, although this finding is not specific for IgG4-RD [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1">Ultrasound may be useful to distinguish salivary gland enlargement due to Sjögren’s disease versus IgG4-RD [<a href="#rid31">31</a>]. On ultrasound, diffuse inhomogeneity of the salivary gland with anechoic or hypoechoic areas is more characteristic of Sjögren’s disease than other causes. Other imaging modalities (eg, CT, MRI) may detect enlargement of the salivary glands consistent with IgG4-RD. However, findings from these other imaging modalities are not specific for IgG4-RD.</p><p></p><p class="headingAnchor" id="H260960743"><span class="h2">Dacroadenitis and ocular and orbital inflammatory disease</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nomenclature</strong> – Many patients diagnosed as having idiopathic orbital inflammation, orbital benign lymphoid hyperplasia, or idiopathic orbital myositis would now be diagnosed as having a form of IgG4-RD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – IgG4-related ophthalmic disease is encountered in approximately 17 to 23 percent of patients with IgG4-RD and may involve the orbital and periorbital tissues, including the extraocular muscles [<a href="#rid32">32-34</a>]. IgG4-RD appears to account for 25 to 50 percent of orbital pseudotumors. Depending upon the diagnostic criteria used, IgG4-RD accounts for approximately 5 to 25 percent of cases originally diagnosed as nongranulomatous idiopathic orbital inflammation [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – IgG4-related ophthalmologic disease presents clinically as proptosis and periocular swelling [<a href="#rid36">36,37</a>]. IgG4-related dacryoadenitis may also lead to dry eyes and is typically bilateral, even though the onset of clinical disease in the two glands may be asynchronous. Concurrent salivary gland involvement is common, and extra-ophthalmic manifestations are seen in approximately 70 to 80 percent of patients with IgG4-related salivary disease [<a href="#rid32">32-34</a>]. (See <a class="local">'Salivary gland involvement'</a> above.)</p><p></p><p class="bulletIndent1">IgG4-related ophthalmologic disease may present concurrently with lymphoma of the head and neck. It is not certain whether IgG4-RD predisposes to the development of ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas or other lymphomas [<a href="#rid38">38-40</a>]. One study has indicated that a history of malignancy may itself be a risk factor for the development of IgG4-RD, rather than the converse [<a href="#rid41">41</a>]. However, a meta-analysis of 10 studies found that the standardized incidence ratio (SIR) for lymphoma in IgG4-RD patients was higher in patients with IgG4-RD compared with the general population (SIR 69.2) [<a href="#rid42">42</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging features</strong> – Both CT and MRI may identify enlargement of the extraocular structures, although these findings are not diagnostic of IgG4-RD. In a study of 27 patients with IgG4-RD affecting the orbits, bilateral enlargement of the extraocular muscles, especially the lateral rectus, was the most common finding, although a minority of patients also had an infiltrative process affecting the orbital fat (44 percent) or optic nerve (30 percent) [<a href="#rid43">43</a>].</p><p></p><p class="headingAnchor" id="H1511872566"><span class="h2">Retroperitoneal fibrosis and related disorders</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nomenclature</strong> – Sclerosing mesenteritis, sclerosing mediastinitis, and multifocal fibrosclerosis are all forms of retroperitoneal fibrosis (RPF), which are often due to IgG4-RD [<a href="#rid44">44-46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – IgG4-RD is responsible for approximately 30 to 60 percent of all RPF cases [<a href="#rid47">47</a>]. Retroperitoneal fibrosis is one of the most commonly encountered subsets of IgG4-RD, affecting 3 to 19 percent of these patients [<a href="#rid47">47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – IgG4-related RPF generally involves the infrarenal aorta and the iliac arteries simultaneously. Extraperitoneal involvement (eg, obstructive uropathy) concurs in most cases [<a href="#rid47">47-49</a>]. Clinically, patients with RPF may present with flank pain due to obstructive uropathy and hydronephrosis. Other manifestations of obstructive uropathy are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7174.html" rel="external">"Clinical manifestations and diagnosis of urinary tract obstruction (UTO) and hydronephrosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1">IgG4-related RPF can also present with nonspecific symptoms such as low back or abdominal pain. Acute phase reactants and IgG4 serum levels are often normal (or lower on average than the levels usually observed in other patients with IgG4-RD) [<a href="#rid47">47,50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging features</strong> – CT and MRI may identify a soft tissue density around the aorta and iliac arteries, which may not enhance. Both modalities may be used to evaluate for ureteral obstruction, but MRI has the advantage of not requiring intravenous contrast. MRI of the mass may be hypointense on T2 imaging, unless there is active inflammation, in which case the T2 images may be hyperintense [<a href="#rid51">51</a>].</p><p></p><p class="headingAnchor" id="H3889661158"><span class="h2">Vascular involvement</span><span class="headingEndMark"> — </span>IgG4-RD vascular involvement is seen in approximately 15 to 25 percent of patients with IgG4-RD [<a href="#rid52">52-55</a>].</p><p>Patients with IgG4-related periaortitis and aortitis generally have nonspecific symptoms caused by the aneurysm (when present) or by the impingement of adjacent tissues (eg, ureters, leading to hydronephrosis) [<a href="#rid47">47,52</a>]. Acute phase reactants and IgG4 serum levels are usually but not always elevated [<a href="#rid47">47</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>IgG4-related periaortitis</strong> – Periaortitis, which may include RPF, is encountered in approximately 20 to 36 percent of patients with IgG4-RD [<a href="#rid47">47,56</a>]. IgG4-related periaortitis typically involves the infrarenal abdominal aorta and the iliac vessels [<a href="#rid47">47</a>]. The thoracic aorta may be involved in approximately 12 percent of patients [<a href="#rid56">56</a>]. Inflammatory abdominal aortitis is associated with RPF and may be discovered incidentally during an evaluation for RPF [<a href="#rid57">57</a>]. (See <a class="local">'Retroperitoneal fibrosis and related disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>IgG4-related aortitis</strong> – IgG4-related aortitis is present in approximately 8 percent of patients with IgG4-RD and represents between 2 and 9 percent of all patients with noninfectious aortitis [<a href="#rid58">58,59</a>]. IgG4-related aortitis has been reported to affect males between the ages of 65 and 74 [<a href="#rid57">57</a>].</p><p></p><p class="bulletIndent1">Patients with IgG4-related aortitis may have prominent aortic atherosclerosis [<a href="#rid57">57,59</a>] (see <a class="local">'Other organ involvement and multisystem disease'</a> below). The thoracic aorta is more commonly affected than the abdominal aorta [<a href="#rid47">47</a>]. The iliac, carotid, and coronary arteries can also be involved [<a href="#rid55">55,60</a>]. Arterial wall thickening is typical of IgG4-related vascular disease, but aneurysms and stenoses have also been described [<a href="#rid55">55,61</a>].</p><p></p><p class="bulletIndent1">The imaging characteristics of IgG4-related aortitis are similar to the aortitis of Takayasu arteritis. Imaging of aortitis is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8238.html" rel="external">"Clinical features and diagnosis of Takayasu arteritis"</a> and  <a class="medical medical_review" href="/z/d/html/8238.html" rel="external">"Clinical features and diagnosis of Takayasu arteritis", section on 'Imaging'</a>.)</p><p></p><p class="headingAnchor" id="H1546101045"><span class="h2">Other manifestations</span><span class="headingEndMark"> — </span>IgG4-RD may also affect the thyroid, lung, kidneys, and other organs.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thyroid disease</strong> – Riedel's thyroiditis is IgG4-RD of the thyroid gland. It is a rare form of thyroiditis that presents as a hard goiter that can produce symptoms related to pressure on adjacent tissues (eg, dyspnea, dysphagia, hoarseness). Cytology is not always diagnostic, and the diagnosis is usually made after thyroid resection, which is often performed to rule out malignancy and to alleviate clinical symptoms [<a href="#rid62">62</a>]. On biopsy, storiform fibrosis, presence of obliterative phlebitis, and an elevated IgG4 to IgG ratio are suggestive of Riedel's thyroiditis. Other forms of thyroiditis, such as chronic autoimmune (Hashimoto's) thyroiditis, may also exhibit some of these features but are not considered to be part of the IgG4-RD spectrum. Riedel's thyroiditis is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7861.html" rel="external">"Infiltrative thyroid disease", section on 'Riedel's thyroiditis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lung and pleural disease</strong> – Multiple reports have demonstrated IgG4-related respiratory disease, which may be asymptomatic or present with cough, hemoptysis, dyspnea, pleurisy, or chest pain.</p><p></p><p class="bulletIndent1">Four patterns of lung involvement have been described [<a href="#rid63">63,64</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Solid nodular</p><p class="bulletIndent2"><span class="glyph">•</span>Bronchovascular (with thickening of bronchovascular bundles and interlobular septa)</p><p class="bulletIndent2"><span class="glyph">•</span>Alveolar interstitial (with honeycombing, bronchiectasis, and diffuse ground-glass opacities)</p><p class="bulletIndent2"><span class="glyph">•</span>Round-shaped, ground-glass opacities</p><p></p><p class="bulletIndent1">Visceral or parietal pleural thickening may also occur. </p><p></p><p class="bulletIndent1">Sclerosing mediastinitis, mediastinal adenopathy, and hilar adenopathy have been described in patients with IgG4-RD and may lead to airway narrowing from lymph node enlargement or mediastinal fibrosis with airway entrapment [<a href="#rid65">65,66</a>]. However, tracheobronchial stenosis has also been described in patients without lymph node enlargement [<a href="#rid67">67,68</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney disease</strong> – There are no imaging findings specific to IgG4-related kidney disease, although extrarenal manifestations may help establish the diagnosis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tubulointerstitial nephritis</strong> – The most common manifestation of IgG4-related kidney disease is tubulointerstitial nephritis (TIN) [<a href="#rid69">69-72</a>]. IgG4-related interstitial nephritis most often presents with signs of acute or chronic kidney injury, mass lesion(s) in the kidney (potentially mimicking renal cell carcinoma), or both. Patients with IgG4-related kidney disease tend to be middle-aged (or older) males. Other clinical manifestations of acute interstitial nephritis is described in greater detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent2">In a retrospective study of 153 patients with suspected IgG4-RD, 15 percent had TIN secondary to IgG4-RD, almost all of whom (96 percent) had other organ involvement, including sialadenitis, lymphadenopathy, AIP, dacryoadenitis, and lung lesions [<a href="#rid72">72</a>]. Symptoms were usually associated with the extrarenal manifestations rather than the kidney abnormalities.</p><p></p><p class="bulletIndent2">Urinalysis is not useful for establishing a diagnosis of IgG4-related TIN. However, IgG4-related TIN may present with hypocomplementemia, which is a risk factor for relapse [<a href="#rid8">8,73</a>].</p><p></p><p class="bulletIndent2">The histopathology and other laboratory characteristics of IgG4-related TIN are similar to those observed in patients with type 1 AIP [<a href="#rid72">72</a>]. (See <a class="local">'Autoimmune pancreatitis'</a> above.).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>IgG4-related membranous nephropathy</strong> – IgG4-related membranous nephropathy is much less common than IgG4-related TIN, but these two kidney complications sometimes occur together [<a href="#rid74">74</a>]. In a series of nine patients with IgG4-related membranous glomerulonephritis (GN), five patients had concurrent IgG4-related TIN, and seven exhibited extrarenal involvement with IgG4-RD [<a href="#rid74">74,75</a>]. None of the patients with IgG4-RD was positive for the presence of anti-phospholipase A2 receptor (anti-PLA2R) antibodies on kidney biopsy tissues, in contrast to the majority (70 percent) of patients with primary membranous GN.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other involved organs and tissues</strong> – Involvement of other organs and tissues by IgG4-RD, which has been described in additional case reports and small case series, includes:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin disease, including a subset of cutaneous pseudolymphoma. The lesions typically appear on the scalp, face, neck, and pinna of the ear [<a href="#rid76">76-78</a>]. Papules, plaques, and nodules are common cutaneous manifestations, while macules and bullae are rarely seen [<a href="#rid79">79</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IgG4-hepatopathy, resembling autoimmune hepatitis, and hepatic inflammatory pseudotumor [<a href="#rid80">80,81</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lymphoplasmacytic gastritis [<a href="#rid82">82</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sclerosing mastitis and inflammatory pseudotumors of the breast [<a href="#rid83">83,84</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Central nervous system (CNS) involvement, with hypopituitarism associated with IgG4-related hypophysitis [<a href="#rid85">85,86</a>] and pachymeningitis being the most common manifestations [<a href="#rid87">87</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prostatitis [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IgG4-RD of the ovary [<a href="#rid89">89</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Constrictive pericarditis [<a href="#rid5">5,90,91</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Nasopharyngeal disease [<a href="#rid92">92,93</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Midline-destructive lesion of the nose [<a href="#rid94">94</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Amyloidosis, described in a patient who developed renal amyloidosis in the context of IgG4-RD [<a href="#rid95">95</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Coronary artery disease with aneurysm formation [<a href="#rid60">60,96-98</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fasciitis [<a href="#rid99">99</a>].</p><p></p><p class="headingAnchor" id="H1675067780"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H2137142862"><span class="h2">In whom to suspect</span><span class="headingEndMark"> — </span>The possibility of immunoglobulin G4-related disease (IgG4-RD) should be suspected in patients with one of the characteristic patterns of organ or tissue involvement. (See <a class="local">'Clinical features'</a> above.)</p><p>In particular, IgG4-RD should be suspected in individuals with any of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Pancreatitis of unknown origin</p><p class="bulletIndent1"><span class="glyph">●</span>Sclerosing cholangitis</p><p class="bulletIndent1"><span class="glyph">●</span>Bilateral salivary and/or lacrimal gland enlargement</p><p class="bulletIndent1"><span class="glyph">●</span>Retroperitoneal fibrosis (RPF)</p><p class="bulletIndent1"><span class="glyph">●</span>Orbital pseudotumor or proptosis</p><p class="bulletIndent1"><span class="glyph">●</span>Development of an otherwise unexplained mass lesion in any of the following organs: pancreas, biliary tree, orbits, lungs, kidneys, major salivary gland, or lacrimal gland</p><p></p><p>The combination of biliary tract and pancreatic disease, or isolated involvement of the bilateral submandibular glands, is nearly diagnostic of IgG4-RD.</p><p>For other presentations, the likelihood of IgG4-RD for patients presenting with at least one of these conditions is significantly increased if the serum concentration of IgG4 is substantially elevated. (See <a class="local">'Serum IgG4'</a> below.).</p><p>In some cases, a serum IgG4 is tested as part of a broad evaluation for evidence of autoimmunity. While we do not suggest this approach, finding a serum IgG4 concentration greater than five times the upper limit of normal should prompt consideration of IgG4-RD. However, an elevated serum IgG4 by itself is inadequate to establish a diagnosis of IgG4-RD.</p><p class="headingAnchor" id="H2376496741"><span class="h2">History and physical</span><span class="headingEndMark"> — </span>In general, the history and physical examination are not diagnostic of IgG4-RD. The goal of the history and physical is to identify manifestations that are potentially consistent with specific forms of IgG4-RD. These manifestations may assist with identifying the appropriate diagnostic tests to establish the diagnosis and to track the patient’s response to therapy over time. The history and physical should also be used to identify other potential sites of IgG4-RD involvement. (See <a class="local">'Clinical features'</a> above.)</p><p>The clinical features of IgG4-RD are subacute, typically developing over several months. Examples of IgG4-RD manifestations that can be detected on history and physical examination include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Enlargement of the salivary glands on examination may be indicative of IgG4-RD. The salivary glands are typically nontender on examination. Bilateral involvement is most common, although patients may present with unilateral disease. (See <a class="local">'Salivary gland involvement'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Painless swelling in the superolateral orbit or eyelid swelling may be indicative of dacryoadenitis of the lacrimal glands, which is commonly associated with IgG4-RD. Involvement may be unilateral or bilateral. (See <a class="local">'Dacroadenitis and ocular and orbital inflammatory disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ocular pain, diplopia, and proptosis may be the result of IgG4-related orbital disease, either through the development of an orbital pseudotumor or involvement of the extraocular muscles. Any diplopia associated with IgG4-RD should resolve when either eye is closed. (See <a class="local">'Dacroadenitis and ocular and orbital inflammatory disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pruritus and jaundice may be late findings of autoimmune pancreatitis (AIP) type 1 or sclerosing cholangitis. (See <a class="local">'Autoimmune pancreatitis'</a> above.)</p><p></p><p>Other forms of IgG4-RD are discovered incidentally on imaging or as part of an evaluation of organ dysfunction. (See <a class="local">'Clinical features'</a> above.)</p><p class="headingAnchor" id="H349458795"><span class="h2">Laboratory evaluation</span></p><p class="headingAnchor" id="H1515655019"><span class="h3">Serum IgG4</span><span class="headingEndMark"> — </span>We suggest measuring serum IgG4 levels in all patients suspected of IgG4-RD. Serum IgG4 is above the upper limit of normal in approximately two-thirds of patients with IgG4-RD and in the correct clinical setting may be strongly suggestive of a diagnosis of IgG4-RD. However, an elevated serum IgG4 in isolation cannot establish the diagnosis because of the following limitations:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>High serum IgG4 is not diagnostic for IgG4-RD</strong> – An IgG4 level by itself is never adequate to establish the diagnosis of IgG4-RD in the absence of clinical and histopathologic confirmation.</p><p></p><p class="bulletIndent1">Very high levels of serum IgG4 do not exclude alternative diagnoses. In a study examining 32,206 cases, 191 patients had IgG4 serum levels &gt;5 times the upper normal limit; 25 percent had alternative diagnoses, such as malignancies, other autoimmune diseases, and infections [<a href="#rid100">100</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Normal IgG4 does not rule out IgG4-RD</strong> – Serum IgG4 is normal in approximately 30 percent of patients who are ultimately diagnosed with IgG4-RD. A normal serum IgG4 level does not exclude this diagnosis [<a href="#rid8">8,11,101,102</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prozone effect may lead to false-negative IgG4 assays</strong> – The prozone effect describes false-negative IgG4 assays that occur in patients with very high levels of IgG4. The prozone effect may be corrected by dilution of the serum sample to reduce the antibody concentration.</p><p></p><p class="bulletIndent1">This affect may explain some false-negative results in patients with a definite diagnosis of IgG4-RD. In one study, 10 of 38 patients with IgG4-RD had falsely low serum IgG4 levels because of the prozone effect [<a href="#rid103">103</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Optimal IgG4 threshold for diagnosis unclear</strong> – A single cutoff is inadequate to evaluate serum IgG4 among patients with IgG4-RD. One study of serum IgG4 concentration measurements at a single institution over a 10-year period (2001 to 2011) compared 190 patients who had elevated serum IgG4 concentrations (mean: 234 mg/dL; range 135 to 1180 mg/dL) with 190 patients with normal IgG4 concentrations [<a href="#rid101">101</a>]. The study found the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The sensitivity of elevated serum IgG4 for a diagnosis of IgG4-RD was 90 percent. Sixty-five of the 72 patients with either definite or probable IgG4-RD had elevated serum IgG4 concentrations (mean: 405 mg/dL; range: 140 to 2000 mg/dL).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The specificity of elevated serum IgG4 for a diagnosis of IgG4-RD was 60 percent. Among the 308 subjects without IgG4-RD, 125 had elevated IgG4 levels (mean: 234 mg/dL; range: 135 to 1180 mg/dL) and 183 had normal IgG4 concentrations.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The negative predictive value of a serum IgG4 assay in these particular groups who were tested was 96 percent, but the positive predictive value was only 34 percent.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Analysis of the serum IgG4 to total IgG ratio did not improve these test characteristics.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Doubling the cutoff for IgG4 improved the specificity (91 percent) but decreased the sensitivity to only 35 percent.</p><p></p><p class="headingAnchor" id="H3859757207"><span class="h3">Other laboratory tests</span><span class="headingEndMark"> — </span>For patients with suspected IgG4, we check:</p><p class="bulletIndent1"><span class="glyph">●</span>Total IgG</p><p class="bulletIndent1"><span class="glyph">●</span>IgG subclasses</p><p class="bulletIndent1"><span class="glyph">●</span>IgE</p><p class="bulletIndent1"><span class="glyph">●</span>C3</p><p class="bulletIndent1"><span class="glyph">●</span>C4</p><p class="bulletIndent1"><span class="glyph">●</span>Serum protein electrophoresis (SPEP)</p><p></p><p>Patients with IgG4-RD often have elevated serum IgG4, IgG1, IgE, and hypocomplementemia. Large studies for the latter are lacking, but its frequency at the time of IgG4-RD diagnosis seems to be between 20 and 40 percent. Of note, there are data suggesting that hypocomplementemia at the time of diagnosis is linked with more active disease [<a href="#rid104">104,105</a>].</p><p>Additionally, IgG4-RD patients have polyclonal hypergammaglobulinemia with beta-gamma bridging, indicative of an inflammatory state [<a href="#rid106">106</a>]. Thus, an SPEP or total immunoglobulins can be useful in the initial evaluation of patients with possible IgG4-RD. However, serial monitoring is generally not indicated.</p><p>Other laboratory tests should be guided by the clinical manifestations. We do not test all patients suspected of IgG4-RD for every serologic abnormality that could potentially be associated with this diagnosis. However, some abnormalities may be identified as part of a broad clinical investigation that eventually leads to a diagnosis of IgG4-RD (see <a class="local">'Clinical features'</a> above). For example:</p><p class="bulletIndent1"><span class="glyph">●</span>Cholestasis (including an elevated bilirubin and alkaline phosphatase) may be indicative of either AIP or IgG4-related sclerosing cholangitis. (See <a class="local">'Autoimmune pancreatitis'</a> above and <a class="local">'IgG4-related sclerosing cholangitis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An elevated serum creatinine may be indicative of post-obstructive kidney disease, which can be caused by retroperitoneal fibrosis (RPF) occluding the ureter. (See <a class="local">'Retroperitoneal fibrosis and related disorders'</a> above.)</p><p></p><p>Other laboratory tests may be more useful to exclude alternate diagnoses. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H4208279294"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Identification of a mass or organ enlargement on imaging often raises suspicion for IgG4-RD. In patients who have not yet undergone imaging, we obtain imaging of the specific area of suspected involvement.</p><p>We use CT in most cases, although it cannot distinguish active inflammation from fibrosis, even with the use of contrast.</p><p>Positron emission tomography (PET) is a reasonable alternative, particularly when vascular involvement is suspected, although it may not be widely available. Additionally, masses associated with IgG4-RD may not be PET avid.</p><p>No imaging findings are diagnostic of IgG4-RD, and imaging findings may not distinguish IgG4-RD from other diagnoses.</p><p>Issues regarding the imaging of specific manifestations of IgG4-RD are discussed above. (See <a class="local">'Clinical features'</a> above.)</p><p class="headingAnchor" id="H381983940"><span class="h2">Biopsy</span></p><p class="headingAnchor" id="H636617556"><span class="h3">Role and performance of biopsy</span><span class="headingEndMark"> — </span>We strongly prefer confirmation of the diagnosis by biopsy of an involved organ whenever possible. However, although histopathology findings are important to the diagnosis of IgG4-RD, such findings alone are never diagnostic of IgG4-RD. Diagnosing IgG4-RD requires consideration of the clinical, serological, radiologic, and pathologic data and exclusion of potential mimickers (eg, malignancy). (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Core needle biopsy adequate for most patients</strong> – How to perform the biopsy depends upon which target organ will be biopsied and whether a discrete mass is present. A core needle biopsy is often adequate, but fine-needle aspirates do not provide adequate tissue [<a href="#rid11">11,23</a>].</p><p></p><p class="bulletIndent1">In a study reevaluating 72 biopsies from patients with IgG4-RD, core needle biopsies were comparable to surgical biopsies with regards to demonstrating features of IgG4-RD [<a href="#rid107">107</a>]. However, surgical biopsies displayed higher numbers of IgG4+ cells per high-power field (HPF).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Selection of biopsy site</strong> – In patients with multi-organ involvement, we do not biopsy all involved organs. Instead, we select a single organ to biopsy based on practical considerations (eg, accessibility of organ). We also do not use lip, lymph node, or gastrointestinal tract biopsies to establish the diagnosis for the following reasons:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In patients with IgG4-RD with salivary gland involvement, a lip biopsy (ie, biopsy of labial minor salivary glands) is helpful mainly to exclude other diseases such as Sjögren’s disease and lymphomas, but its sensitivity is quite low in diagnosing IgG4-RD. Biopsy of submandibular glands is more sensitive for diagnosing IgG4-RD in patients with swelling of these glands [<a href="#rid108">108,109</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Biopsies of lymph nodes are often problematic to interpret with regard to the diagnosis of IgG4-RD because they seldom undergo the storiform fibrosis that is so highly characteristic of IgG4-RD, and large numbers of IgG4+ plasma cells can be found in multiple diseases in which IgG4-RD is not the diagnosis, resulting in poor specificity of this finding. (See <a class="local">'Lymph node pathology'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Biopsies of the intestinal tract often have a high concentration of IgG4+ plasma cells. Because the gastrointestinal tract is seldom affected in IgG4-RD, biopsies from the gastrointestinal tract should not be relied upon to establish the diagnosis of IgG4-RD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>IgG4 staining</strong> – IgG4 staining should be performed on all biopsies in patients suspected of IgG4-RD, although IgG4+ plasma cells may be seen in a wide range of diagnoses other than IgG4-RD.</p><p></p><p class="bulletIndent1">Staining of previously obtained tissues for IgG4 may provide useful information [<a href="#rid110">110</a>]. Even pathology samples archived for years in paraffin can still yield important diagnostic information. Review of previous biopsies and the performance of appropriate immunostains may obviate the need for a new biopsy.</p><p></p><p class="headingAnchor" id="H1281534254"><span class="h3">Solid organ pathology</span><span class="headingEndMark"> — </span>Biopsies of involved organs frequently demonstrate characteristic histopathologic features and immunohistochemical staining  (<a class="graphic graphic_picture graphicRef93439" href="/z/d/graphic/93439.html" rel="external">picture 1</a>). These findings include:</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoplasmacytic tissue infiltration of mainly IgG4-positive plasma cells and lymphocytes</p><p class="bulletIndent1"><span class="glyph">●</span>Storiform fibrosis</p><p class="bulletIndent1"><span class="glyph">●</span>Obliterative phlebitis</p><p class="bulletIndent1"><span class="glyph">●</span>Tissue eosinophilia</p><p></p><p>However, IgG4 lymphoplasmacytic infiltrates and even storiform fibrosis can also be observed in conditions mimicking IgG4-RD. Such conditions include a variety of malignancies, granulomatosis with polyangiitis (GPA), Castleman disease, and other conditions [<a href="#rid110">110</a>]. Consequently, the diagnosis cannot be predicated entirely upon pathology findings, regardless of the intensity of IgG4-positive plasma cell infiltration.</p><p>For establishing a diagnosis of IgG4-RD, the histopathologic features are more important than tissue IgG4-positive cell counts and the ratios of IgG4- to IgG-positive cells [<a href="#rid5">5,11,23,111,112</a>]. The diagnosis of IgG4-RD cannot be predicated entirely upon the number of IgG4-positive plasma cells for the following reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>Many diseases are associated with large numbers of IgG4-positive plasma cells.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The number of IgG4-positive plasma cells per high-power field (HPF) that is regarded as consistent with or suggestive of IgG4-RD varies somewhat from tissue to tissue.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Generally, the minimum for making the diagnosis for most tissues is from 30 to 50 IgG4-positive cells per HPF.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>However, in some organs or tissues (eg, kidney) only 10 IgG4-positive plasma cells per HPF may be sufficient.</p><p></p><p class="headingAnchor" id="H1370414917"><span class="h3">Lymph node pathology</span><span class="headingEndMark"> — </span>The diagnosis of IgG4-RD should not be predicated only upon a lymph node biopsy. Many conditions can be associated with elevated numbers of IgG4-positive plasma cells in lymph nodes, and the specificity of this finding is poor. (See <a class="local">'Role and performance of biopsy'</a> above.)</p><p>Although we do not recommend lymph node biopsy for establishing the diagnosis of IgG4-RD, lymph node biopsy may be important to exclude other conditions (eg, lymphoma, sarcoidosis, and Castleman disease). (See <a class="local">'Differential diagnosis'</a> below.)</p><p>Lymph node biopsies have been categorized into five histologic patterns, all of which feature abundant IgG4-positive cells. The patterns include:</p><p class="bulletIndent1"><span class="glyph">●</span>Multicentric Castleman disease-like</p><p class="bulletIndent1"><span class="glyph">●</span>Follicular hyperplasia</p><p class="bulletIndent1"><span class="glyph">●</span>Interfollicular expansion</p><p class="bulletIndent1"><span class="glyph">●</span>Progressive transformation of germinal center-like</p><p class="bulletIndent1"><span class="glyph">●</span>Nodal inflammatory pseudotumor-like</p><p></p><p>IgG4-related lymphadenopathy generally demonstrates eosinophil infiltration but lacks fibrosis or phlebitis (which are common features of solid organ pathology in IgG4-RD) [<a href="#rid11">11,113-115</a>]. (See <a class="local">'Solid organ pathology'</a> above.)</p><p class="headingAnchor" id="H3358143792"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H3697562138"><span class="h2">Establishing the diagnosis</span><span class="headingEndMark"> — </span>The diagnosis of immunoglobulin G4-related disease (IgG4-RD) is made when a patient meets both of the following criteria:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical or radiologic evidence of tumor-like swelling of an involved organ.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biopsy of the involved organ that demonstrates:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lymphoplasmacytic infiltrate enriched in IgG4-positive plasma cells</p><p class="bulletIndent2"><span class="glyph">•</span>Storiform fibrosis (typified by a cartwheel appearance of the arranged fibroblasts and inflammatory cells)</p><p class="bulletIndent2"><span class="glyph">•</span>Obliterative phlebitis</p><p></p><p class="bulletIndent1">The presence of these histologic findings  (<a class="graphic graphic_picture graphicRef76767" href="/z/d/graphic/76767.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef93427" href="/z/d/graphic/93427.html" rel="external">picture 3</a>), often together with mild tissue eosinophilia  (<a class="graphic graphic_picture graphicRef93429" href="/z/d/graphic/93429.html" rel="external">picture 4</a>), is strongly suggestive of IgG4-RD  (<a class="graphic graphic_picture graphicRef76767" href="/z/d/graphic/76767.html" rel="external">picture 2</a>) [<a href="#rid11">11,116</a>].</p><p></p><p class="bulletIndent1">The number of IgG4-positive plasma cells per high-power field (HPF) that is regarded as consistent with or suggestive of IgG4-RD varies somewhat from tissue to tissue. (See <a class="local">'Solid organ pathology'</a> above.)</p><p></p><p>A group of IgG4-RD experts from around the globe, under the auspices of American College of Rheumatology (ACR) and European Alliance of Associations for Rheumatology (EULAR), developed the 2019 ACR/EULAR classification criteria for IgG4-related disease [<a href="#rid117">117</a>]. Classification is based on a three-step process as follows [<a href="#rid117">117</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical, radiologic involvement and/or compatible histopathological findings in 1 of 11 organs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Absence of exclusion criteria (32 clinical, serological, radiologic and pathological features).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Scoring ≥20 in eight weighted domains. The cutoff of 20 points offers a specificity and sensitivity of more than 97 and 82 percent when used to distinguish IgG4-RD from mimics of IgG4-RD.</p><p></p><p>However, these classification criteria may not identify all patients with IgG4-RD and should not be used as a substitute for a through clinicopathologic evaluation, as described above. (See <a class="local">'Evaluation'</a> above.)</p><p class="headingAnchor" id="H3532747665"><span class="h2">Features that suggest alternate diagnoses</span><span class="headingEndMark"> — </span>We are cautious in making a diagnosis in a patient who has one of the following features, which may be indicative of infection, malignancy, or another autoimmune disease [<a href="#rid117">117</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent fever in the absence of infection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No objective response of the mass to glucocorticoids (eg, oral <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> 32 mg daily for two weeks)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Specific hematologic abnormalities (eg, simultaneous leukopenia and thrombocytopenia or substantial hypereosinophilia consistent with an idiopathic hypereosinophilic syndrome) (see  <a class="medical medical_review" href="/z/d/html/2211.html" rel="external">"Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis", section on 'Evaluation and diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Autoantibodies suggestive of another autoimmune diagnosis (eg, antineutrophil cytoplasmic antibody, serum cryoglobulins, anti-Ro, La, Sm, ribonucleoprotein, or double-stranded deoxyribonucleic acid [dsDNA] antibodies) (see  <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/3062.html" rel="external">"Mixed cryoglobulinemia syndrome: Clinical manifestations and diagnosis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/4668.html" rel="external">"Clinical manifestations and diagnosis of systemic lupus erythematosus in adults", section on 'Diagnosis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Radiologic features suspicious for malignancy or infection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapid radiologic progression (ie, significant worsening in four to six weeks)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Long bone abnormalities consistent with Erdheim-Chester disease (see  <a class="medical medical_review" href="/z/d/html/13942.html" rel="external">"Erdheim-Chester disease", section on 'Initial evaluation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Splenomegaly [<a href="#rid11">11,23,107,110</a>]</p><p></p><p class="headingAnchor" id="H1523354535"><span class="h2">Postdiagnostic evaluation</span><span class="headingEndMark"> — </span>We do not perform total-body CT scans to detect asymptomatic or subclinical disease manifestations. Instead, we conduct a careful clinical assessment to look for evidence of additional organ involvement, followed by selected radiologic studies. If the radiologic studies identify a mass that is not clearly related to IgG4-RD, biopsy of the relevant organ may help confirm the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/121219.html" rel="external">"Treatment and prognosis of IgG4-related disease", section on 'Pretreatment evaluation'</a>.)</p><p class="headingAnchor" id="H1164135862"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of immunoglobulin G4-related disease (IgG4-RD) is broad and usually depends upon the specific site of involvement and clinical presentation.</p><p>Elevations in serum and tissue IgG4 concentrations are not specific to IgG4-RD; they are also found in other disorders  (<a class="graphic graphic_table graphicRef127149" href="/z/d/graphic/127149.html" rel="external">table 1</a>), some of which have similarities to IgG4-RD clinically, including multicentric Castleman disease, allergic disorders, eosinophilic granulomatosis with polyangiitis (GPA), and sarcoidosis [<a href="#rid118">118,119</a>].</p><p class="headingAnchor" id="H2472477207"><span class="h2">Pancreato-hepato-biliary disease</span><span class="headingEndMark"> — </span>Important mimics of IgG4-related pancreato-hepato-biliary disease included pancreatic cancer, primary sclerosing cholangitis, and cholangiocarcinoma:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pancreatic cancer</strong> – Autoimmune pancreatitis (AIP) may be difficult to distinguish clinically from adenocarcinoma of the pancreas. Painless jaundice may be seen with either condition, and both conditions may have elevated levels of serum IgG4 and IgG4-positive plasma cells in the affected tissue [<a href="#rid120">120</a>]. (See <a class="local">'Autoimmune pancreatitis'</a> above.)</p><p></p><p class="bulletIndent1">Biopsy, either intraoperatively or obtained by endoscopic ultrasound, is the gold standard for distinguishing AIP from pancreatic cancer. However, biopsies obtained by endoscopy generally provide relatively small samples. These can be useful in establishing the diagnosis of malignancy but are not entirely reassuring if negative.</p><p></p><p class="bulletIndent1">When biopsy is nondiagnostic or unavailable, CT scan may be useful to rule out pancreatic cancer. Radiologic features of type 1 AIP that can help differentiate this diagnosis from pancreatic cancer include: diffuse enlargement of the pancreas ("sausage-shaped" pancreas), a halo of edema surrounding the organ, and delayed homogenous enhancement during the portal and venous phases [<a href="#rid121">121,122</a>].</p><p></p><p class="bulletIndent1">When the diagnosis is still not clear, we treat empirically with glucocorticoids (eg, oral <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> 32 mg daily for two weeks). Patients with type 1 AIP usually exhibit substantial radiologic and clinical improvement following such a trial.</p><p></p><p class="bulletIndent1">Adenocarcinoma of the pancreas is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer", section on 'Diagnostic approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Primary sclerosing cholangitis</strong> – Distinguishing primary sclerosing cholangitis from IgG4-related sclerosing cholangitis is crucial because of the drastically different prognoses associated with these conditions. (See <a class="local">'IgG4-related sclerosing cholangitis'</a> above.)</p><p></p><p class="bulletIndent1">Both entities present with cholestatic liver function tests, elevated serum IgG4, and narrowing of the intra- and extrahepatic bile ducts [<a href="#rid123">123</a>]. The clinical presentations and radiologic features of these conditions may be very similar. Additionally, biopsies performed via endoscopic retrograde cholangiopancreatography are seldom sufficiently deep to define the histopathologic features of IgG4-RD [<a href="#rid124">124,125</a>].</p><p></p><p class="bulletIndent1">The following features may help distinguish primary sclerosing cholangitis from IgG4-related sclerosing cholangitis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The simultaneous presence of bile duct involvement and pancreatic disease is nearly diagnostic of IgG4-RD. Isolated bile duct involvement sparing the pancreas can occur in IgG4-RD but is unusual [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Serum IgG4 concentrations greater than four to five times the upper limit of normal strongly favor IgG4-RD.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>When the diagnosis is still not clear, we treat empirically with glucocorticoids (eg, oral <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> 32 mg daily for two weeks); patients who fail to improve symptomatically on this regimen are unlikely to have IgG4-related sclerosing cholangitis.</p><p></p><p class="bulletIndent1">One study has suggested that a composite score, based upon age, other organ involvement, and beaded appearance of the bile duct, is able to differentiate sufficiently between IgG4-related cholangitis and primary sclerosing cholangitis, but this tool needs further validation [<a href="#rid126">126</a>].</p><p></p><p class="bulletIndent1">Primary sclerosing cholangitis is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/660.html" rel="external">"Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cholangiocarcinoma</strong> – Cholangiocarcinoma and IgG4-related sclerosing cholangitis share multiple clinical and radiologic features, which may make these diagnoses difficult to distinguish. (See <a class="local">'IgG4-related sclerosing cholangitis'</a> above.)</p><p></p><p class="bulletIndent1">The following features are more characteristic of cholangiocarcinoma rather than IgG4-related sclerosing cholangitis:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Obstructive jaundice</p><p class="bulletIndent2"><span class="glyph">•</span>An enlarged pancreas</p><p class="bulletIndent2"><span class="glyph">•</span>Lymphadenopathy</p><p class="bulletIndent2"><span class="glyph">•</span>High serum bilirubin</p><p class="bulletIndent2"><span class="glyph">•</span>High serum cancer antigen 19-9</p><p class="bulletIndent2"><span class="glyph">•</span>Complete obstruction of the hilar or bile ducts as demonstrated by endoscopic retrograde cholangiopancreatography</p><p></p><p class="bulletIndent1">A cutoff higher than the standard upper limit of normal for serum IgG4 concentrations (ie, &gt;135 mg/dL) may also be useful in distinguishing IgG4-RD from cholangiocarcinoma; the higher the serum IgG4 concentration, the greater the likelihood that the patient has IgG4-RD rather than a biliary tract malignancy [<a href="#rid127">127</a>].</p><p></p><p class="bulletIndent1">Cholangiocarcinoma is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma", section on 'Diagnostic approach'</a>.)</p><p></p><p class="headingAnchor" id="H1859854426"><span class="h2">Retroperitoneal fibrosis and/or aortitis</span><span class="headingEndMark"> — </span>IgG4-related retroperitoneal fibrosis (RPF), aortitis, and periaortitis need to be differentiated from other causes of RPF and of noninfectious and infectious disorders that may cause aortitis and periaortitis:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Retroperitoneal fibrosis</strong> – Most patients diagnosed with idiopathic RPF actually have IgG4-RD [<a href="#rid57">57,128-131</a>]. (See <a class="local">'Retroperitoneal fibrosis and related disorders'</a> above.)</p><p></p><p class="bulletIndent1">RPF related to IgG4-RD may be differentiated from other causes of RPF based on the histopathologic and clinical findings. Biopsy findings in IgG4-related RPF, in contrast to RPF from other causes, usually have a tissue IgG4+ to IgG+ ratio &gt;40 percent.</p><p></p><p class="bulletIndent1">However, confirmation of the diagnosis of IgG4-RD in this setting is often challenging because diagnostic pathology is often unavailable; when it is available, it often demonstrates nonspecific fibrotic changes.</p><p></p><p class="bulletIndent1">When pathology is unavailable or nondiagnostic, the following features may help distinguish IgG4-related RPF from idiopathic RPF:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Extraperitoneal manifestations are present in more than half of patients with IgG4-related RPF [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Infrarenal periaortitis extending inferiorly to involve the iliac vessels is strongly suggestive of IgG4-related RPF.</p><p></p><p class="bulletIndent1">Idiopathic RPF is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7200.html" rel="external">"Clinical manifestations and diagnosis of retroperitoneal fibrosis", section on 'Distinguishing between primary and secondary disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aortitis and periaortitis</strong> – Both IgG4-RD and a number of noninfectious and infectious disorders can cause aortitis and periaortitis. (See <a class="local">'Vascular involvement'</a> above.)</p><p></p><p class="bulletIndent1">Histopathologic characteristics are most useful for distinguishing IgG4-related and unrelated disease. High numbers of IgG4+ plasmacytes are seen in IgG4-related aortitis, although these can be seen in other aortitis as well. Additional histologic features favoring a diagnosis of IgG4-RD include the presence of storiform fibrosis, lymphoid follicles, and obliterative phlebitis. Granulomatous inflammation, the presence of either epithelioid granulomas or multinucleated giant cells, intense neutrophilic infiltration, and the finding of necrosis all argue strongly against IgG4-RD [<a href="#rid132">132</a>].</p><p></p><p class="bulletIndent1">When histopathology is unavailable or non-diagnostic, elevated serum IgG4, serum IgE, or antinuclear antibodies favors a diagnosis of IgG4-related aortitis over other diseases [<a href="#rid133">133</a>]. Additionally, various epidemiologic, clinical, and histopathologic features serve to differentiate IgG4-RD from other diseases. For example, patients with IgG4-related aortitis are typically older than those with Takayasu arteritis or Behçet syndrome [<a href="#rid134">134</a>]. (See  <a class="medical medical_review" href="/z/d/html/8238.html" rel="external">"Clinical features and diagnosis of Takayasu arteritis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/z/d/html/8223.html" rel="external">"Clinical manifestations and diagnosis of Behçet syndrome", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1">Fevers are extremely unusual in IgG4-RD. In patients with aortitis or periaortitis who present with fever, infection and malignancies, particularly unusual presentations of lymphoma, should be considered [<a href="#rid135">135,136</a>].</p><p></p><p class="bulletIndent1">However, infections, with the possible exception of syphilis (now vanishingly rare as a cause of aortitis), seldom cause diffuse aortic disease. (See  <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Cardiovascular'</a>.)</p><p></p><p class="headingAnchor" id="H1279918555"><span class="h2">Head and neck disease</span><span class="headingEndMark"> — </span>Several conditions that share some features with IgG4-related head and neck disease should be differentiated from IgG4-RD, including Sjögren's disease and orbital inflammatory disease:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sjögren's disease</strong> – Both Sjögren's disease and IgG4-related sialoadenitis and dacryoadenitis can exhibit prominent swelling of the parotid, submandibular, and lacrimal glands. (See <a class="local">'Salivary gland involvement'</a> above and <a class="local">'Dacroadenitis and ocular and orbital inflammatory disease'</a> above.)</p><p></p><p class="bulletIndent1">These diagnoses can generally be distinguished based upon respective characteristic histopathologic and laboratory findings, as well as associated clinical features. For example, unlike Sjögren's disease, IgG4-related sialadenitis is less commonly associated with dry eyes, dry mouth, arthralgias, or autoantibodies (ie, rheumatoid factor, antinuclear antibodies, anti-Ro/SSA antibody, anti-La/SSB antibody) [<a href="#rid111">111</a>].</p><p></p><p class="bulletIndent1">However, compared with Sjögren’s disease, IgG4-related sialadenitis is more commonly associated with allergic rhinitis, bronchial asthma, AIP, and interstitial nephritis.</p><p></p><p class="bulletIndent1">Patients who fulfill criteria for both Sjögren's disease and IgG4-RD have been identified, although most of these patients would be clinically classified as having IgG4-RD [<a href="#rid137">137</a>].</p><p></p><p class="bulletIndent1">Sjögren’s disease is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5603.html" rel="external">"Diagnosis and classification of Sjögren’s disease", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Orbital pseudotumor</strong> – The emergence of IgG4-RD as an important cause of orbital inflammation underscores the importance of performing biopsies in cases of orbital inflammation in which the diagnosis is not completely clear. In children, orbital pseudotumor is a common manifestation of IgG4-RD [<a href="#rid138">138</a>]. However, the possibility of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis as a cause of orbital pseudotumor should be considered. (See <a class="local">'Other manifestations'</a> above and <a class="local">'Other organ involvement and multisystem disease'</a> below.)</p><p></p><p class="headingAnchor" id="H54289942"><span class="h2">Other organ involvement and multisystem disease</span><span class="headingEndMark"> — </span>A range of conditions affecting various organs individually or as multisystem disorders can resemble IgG4-RD, including lung disease, generalized lymphadenopathy, goiter, kidney disease, and ANCA-associated vasculitis:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lung disease</strong> – IgG4-RD of the lungs can exhibit many different and often overlapping patterns. Pulmonary involvement in IgG4-RD can mimic (and be mimicked by) several conditions, including sarcoidosis, neoplasms, ANCA-associated vasculitis, and interstitial lung disease associated with autoimmune diseases. (See <a class="local">'Other manifestations'</a> above.)</p><p></p><p class="bulletIndent1">Features that can help distinguish IgG4-RD from other disorders include an association with other (nonpulmonary) manifestations of IgG4-RD and histopathologic characteristics on biopsy. In IgG4-RD of the lung:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IgG4+ plasma cells are frequent, although storiform fibrosis is not always present in lung biopsies [<a href="#rid139">139,140</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neutrophilic aggregates are sometimes observed in the lung in IgG4-RD, unlike in other tissues in IgG4-RD [<a href="#rid139">139</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The disease extends along the bronchovascular bundle, leading to the thickening of bronchial walls and surrounding tissue [<a href="#rid140">140</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Generalized lymphadenopathy</strong> – IgG4 lymphadenopathy may be difficult to distinguish from lymphadenopathy from other causes (eg, multicentric Castleman disease, Rosai-Dorfman disease, inflammatory myofibroblastic tumor), since the pathologic findings of IgG4 lymphadenopathy may be nonspecific. (See <a class="local">'Lymphadenopathy'</a> above.)</p><p></p><p class="bulletIndent1">Unlike other forms of generalized lymphadenopathy, IgG4 lymphadenopathy generally:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Presents with other clinical or laboratory manifestations of IgG4-RD [<a href="#rid25">25</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Has modest lymph node enlargement</p><p class="bulletIndent2"><span class="glyph">•</span>Lacks constitutional features</p><p class="bulletIndent2"><span class="glyph">•</span>Responds to treatment with glucocorticoids [<a href="#rid11">11</a>]</p><p></p><p class="bulletIndent1">Patients with bilateral hilar lymphadenopathy due to IgG4-RD may be incorrectly diagnosed with sarcoidosis [<a href="#rid141">141,142</a>]. In one study of patients suspected of having sarcoid, a final diagnosis of IgG4-RD was more common among patients with an elevated serum IgG4. Patients with IgG4-RD also had significantly higher IgG4, IgG4/IgG ratio, and IgG4/IgG3 ratio in their bronchoalveolar lavage fluid [<a href="#rid141">141</a>].</p><p></p><p class="bulletIndent1">Pulmonary sarcoid is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Initial evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Goiter</strong> – The fibrosing variant of chronic autoimmune (Hashimoto's) thyroiditis and Riedel's thyroiditis may be difficult to distinguish from IgG4-related autoimmune (Hashimoto's) thyroiditis [<a href="#rid62">62,143-145</a>]. (See <a class="local">'Other manifestations'</a> above.)</p><p></p><p class="bulletIndent1">These diagnoses share some histopathologic characteristics, including an increased IgG4+ to IgG+ ratio in the thyroid gland. Some authors have hypothesized that the fibrosing variant of Hashimoto's thyroiditis might be an early form of Riedel's thyroiditis [<a href="#rid144">144</a>]. The presence of other organ involvement may help distinguish IgG4-related autoimmune thyroiditis from these other diagnoses.</p><p></p><p class="bulletIndent1">Riedel's and Hashimoto's thyroiditis are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7861.html" rel="external">"Infiltrative thyroid disease", section on 'Riedel's thyroiditis'</a> and  <a class="medical medical_review" href="/z/d/html/7886.html" rel="external">"Disorders that cause hypothyroidism", section on 'Chronic autoimmune (Hashimoto's) thyroiditis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Kidney disease</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tubulointerstitial nephritis</strong> – Other forms of interstitial nephritis can mimic IgG4-related tubulointerstitial nephritis (TIN). (See <a class="local">'Other manifestations'</a> above.)</p><p></p><p class="bulletIndent2">These include drug-related interstitial nephritis, chronic pyelonephritis, multicentric Castleman disease, and interstitial nephritis related to other autoimmune diseases (eg, Sjögren's disease, GPA).</p><p></p><p class="bulletIndent2">On biopsy, there is an abundance of IgG4+ plasmacytes and storiform fibrosis, with tubular basement membrane immune complex deposition, but granulomatous inflammation, marked neutrophilic infiltration, and karyorrhexis are absent [<a href="#rid146">146</a>].</p><p></p><p class="bulletIndent2">Interstitial nephritis is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Membranous glomerulonephritis</strong> – Idiopathic membranous glomerulonephritis (GN) may be difficult to distinguish from IgG4-associated membranous GN. However, immunostaining of the kidney tissue for the presence of anti-phospholipase A2 receptor (anti-PLA2R) antibodies may help distinguish these diagnoses.</p><p></p><p class="bulletIndent2">In a series of nine patients with IgG4-related membranous GN, none of the patients with IgG4-RD had evidence of anti-PLA2R on kidney biopsy, although it is present in a majority of patients with primary membranous GN [<a href="#rid74">74,75</a>]. The presence of extrarenal manifestations of IgG4-RD may also help confirm the diagnosis of IgG4-associated membranous GN.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Granulomatosis with polyangiitis</strong> <strong>–</strong> IgG4-RD sometimes presents as GPA with atypical features, such as pachymeningitis, orbital mass, or chronic periaortitis [<a href="#rid147">147,148</a>] (see <a class="local">'Dacroadenitis and ocular and orbital inflammatory disease'</a> above and <a class="local">'Vascular involvement'</a> above and <a class="local">'Other manifestations'</a> above). Moreover, tissue biopsies from patients with GPA can have substantial infiltrates of IgG4-positive plasma cells.</p><p></p><p class="bulletIndent1">The pattern of organ involvement and signs of inflammation may help distinguish these entities. The ears, nose, throat, lungs, and kidneys are more commonly affected in GPA, while pancreatitis, RPF, and salivary and lacrimal gland involvement are more commonly encountered in IgG4-RD. In IgG4-RD, fever is less common and levels of C-reactive protein are lower compared with GPA [<a href="#rid149">149</a>].</p><p></p><p class="bulletIndent1">Granulomatosis with polyangiitis is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vascular disease</strong> – Some patients diagnosed with an inflammatory abdominal aortic aneurysm actually have IgG4-RD [<a href="#rid150">150</a>]. An inflammatory abdominal aortic aneurysm is a form of chronic periaortitis that is associated with atherosclerotic disease and often presents with retroperitoneal fibrosis and acute phase reactant elevation.</p><p></p><p class="bulletIndent1">In a study of 114 patients with abdominal aortic aneurysms who required surgery, 7 patients (6 percent) had pathologic findings consistent with IgG4-RD [<a href="#rid151">151</a>]. Only two of these patients had elevated serum IgG4 levels (ie, more than 1.35 g/L).</p><p></p><p>Because atherosclerotic inflammatory abdominal aortic aneurysms and IgG4-related periaortitis share many features, these diagnoses may be difficult to distinguish clinically. However, both diagnoses are treated with glucocorticoids, which may decrease the importance of differentiating these two diagnoses [<a href="#rid152">152</a>]. In a series of five patients with inflammatory abdominal aortic aneurysms treated with <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> 5 mg twice daily, all patients experienced pain relief within a few weeks and radiographic improvement over 18 months [<a href="#rid153">153</a>]. However, the optimal dose and duration of glucocorticoid therapy for inflammatory abdominal aortic aneurysms is unclear.</p><p>The diagnosis and management of abdominal aortic aneurysms is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15191.html" rel="external">"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm", section on 'Symptomatic (non-ruptured) AAA'</a> and  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Diagnosis'</a>.)</p><p class="headingAnchor" id="H1310050566"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117964.html" rel="external">"Society guideline links: IgG4-related disease"</a>.)</p><p class="headingAnchor" id="H1428928989"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Patients often present with subacute development of a mass or diffuse enlargement of the affected organ. Patients may be asymptomatic.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Autoimmune pancreatitis</strong> – Type 1 autoimmune pancreatitis (AIP; ie, lymphoplasmacytic sclerosing pancreatitis) is associated with immunoglobulin G4 (IgG4-RD). It can present as a pancreatic mass, painless obstructive jaundice, or pancreatitis. On CT, the pancreas is diffusely enlarged and surrounded by a halo of edema. However, radiologic studies do not distinguish type 1 AIP from type 2 AIP (which is not associated with IgG4-RD). (See <a class="local">'Autoimmune pancreatitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>IgG4-related sclerosing cholangitis</strong> – IgG4-related sclerosing cholangitis may present with abdominal discomfort, diarrhea, malaise, jaundice, and pruritus. Biliary tract imaging of IgG4-related sclerosing cholangitis demonstrates diffuse or segmental narrowing of the intra- and/or extrahepatic bile duct, associated with thickening of the bile duct wall. However, radiologic studies may not distinguish IgG4-related sclerosing cholangitis from primary sclerosing cholangitis, pancreatic cancer, or cholangiocarcinoma. (See <a class="local">'IgG4-related sclerosing cholangitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lymphadenopathy</strong> – Lymphadenopathy may be observed in the mediastinal, hilar, intrabdominal, or axillary regions and is commonly asymptomatic at the time of presentation. Lymph node biopsies are nonspecific, since increased numbers of IgG4 cells may be seen in lymph nodes for a variety of reasons. (See <a class="local">'Lymphadenopathy'</a> above and <a class="local">'Lymph node pathology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other manifestations</strong> – IgG4-RD may present as sialadenitis, dacryoadenitis, orbital pseudotumor, orbital myositis, retroperitoneal fibrosis (RPF), aortitis, and periaortitis. IgG4-RD may also involve the thyroid, lung, kidney, and other organ systems. (See <a class="local">'Salivary gland involvement'</a> above and <a class="local">'Dacroadenitis and ocular and orbital inflammatory disease'</a> above and <a class="local">'Retroperitoneal fibrosis and related disorders'</a> above and <a class="local">'Vascular involvement'</a> above and <a class="local">'Other manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – IgG4-RD should be suspected in any patient presenting with any of the following (see <a class="local">'In whom to suspect'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pancreatitis of unknown origin</p><p class="bulletIndent2"><span class="glyph">•</span>Sclerosing cholangitis</p><p class="bulletIndent2"><span class="glyph">•</span>Bilateral salivary and/or lacrimal gland enlargement</p><p class="bulletIndent2"><span class="glyph">•</span>RPF</p><p class="bulletIndent2"><span class="glyph">•</span>Orbital pseudotumor or proptosis</p><p class="bulletIndent2"><span class="glyph">•</span>Development of a mass lesion in any of the following organs: pancreas, biliary tree, orbits, lungs, kidneys, major salivary gland, or lacrimal gland</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of IgG4-RD requires clinical or radiologic evidence of tumor-like swelling of an involved organ and a biopsy that demonstrates a lymphoplasmacytic infiltrate enriched in IgG4-positive plasma cells (eg, 30 to 50 per high-power field [HPF]), storiform fibrosis, and obliterative phlebitis. Serum IgG4 is elevated in two-thirds of patients. Some patients with IgG4-RD have hypocomplementemia and elevated serum IgG1 and IgE. However, IgG4-RD is a clinical diagnosis; serum, histologic, and radiologic studies are not diagnostic in isolation. (See <a class="local">'Diagnosis'</a> above and <a class="local">'Biopsy'</a> above and <a class="local">'Laboratory evaluation'</a> above and <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1">The following features make IgG4-RD less likely:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Persistent fever</p><p class="bulletIndent2"><span class="glyph">•</span>No response to glucocorticoids</p><p class="bulletIndent2"><span class="glyph">•</span>Simultaneous leukopenia and thrombocytopenia</p><p class="bulletIndent2"><span class="glyph">•</span>Hypereosinophilia</p><p class="bulletIndent2"><span class="glyph">•</span>Autoantibodies suggestive of another autoimmune diagnosis (eg, antineutrophil cytoplasmic antibody [ANCA], serum cryoglobulins, anti-Ro, La, Sm, ribonucleoprotein, or dsDNA antibodies)</p><p class="bulletIndent2"><span class="glyph">•</span>Radiologic features suspicious for malignancy or infection</p><p class="bulletIndent2"><span class="glyph">•</span>Rapid radiologic progression (ie, significant worsening in four to six weeks)</p><p class="bulletIndent2"><span class="glyph">•</span>Long bone abnormalities consistent with Erdheim-Chester disease</p><p class="bulletIndent2"><span class="glyph">•</span>Splenomegaly</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of IgG4-RD is broad and usually depends upon the specific site of involvement and clinical presentation. Elevations in serum and tissue IgG4 concentrations are not specific to IgG4-RD and may be found in a wide range of unrelated disorders  (<a class="graphic graphic_table graphicRef127149" href="/z/d/graphic/127149.html" rel="external">table 1</a>). Clinical assessment, radiologic studies, histology, and response to empiric courses of glucocorticoids (eg, <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> 32 mg daily for two weeks) may all play a role in distinguishing IgG4-RD from other causes. (See <a class="local">'Differential diagnosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012; 366:539.</a></li><li><a class="nounderline abstract_t">Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 2015; 385:1460.</a></li><li><a class="nounderline abstract_t">Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheumatol 2019; 1:e55.</a></li><li><a class="nounderline abstract_t">Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38:982.</a></li><li><a class="nounderline abstract_t">Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23:57.</a></li><li><a class="nounderline abstract_t">Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011; 46:277.</a></li><li><a class="nounderline abstract_t">Wallace ZS, Miles G, Smolkina E, et al. Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis 2023; 82:957.</a></li><li><a class="nounderline abstract_t">Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol 2015; 67:2466.</a></li><li><a class="nounderline abstract_t">Brito-Zerón P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun Rev 2014; 13:1203.</a></li><li><a class="nounderline abstract_t">Takahashi H, Yamamoto M, Suzuki C, et al. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 2010; 9:591.</a></li><li><a class="nounderline abstract_t">Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010; 17:303.</a></li><li><a class="nounderline abstract_t">Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010; 139:140.</a></li><li><a class="nounderline abstract_t">Fritz S, Bergmann F, Grenacher L, et al. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2. Br J Surg 2014; 101:1257.</a></li><li><a class="nounderline abstract_t">Hart PA, Levy MJ, Smyrk TC, et al. Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience. Gut 2016; 65:1702.</a></li><li><a class="nounderline abstract_t">Hart PA, Zen Y, Chari ST. Recent Advances in Autoimmune Pancreatitis. Gastroenterology 2015; 149:39.</a></li><li><a class="nounderline abstract_t">Nishimori I, Tamakoshi A, Otsuki M, Research Committee on Intractable Diseases of the Pancreas, Ministry of Health, Labour, and Welfare of Japan. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007; 42 Suppl 18:6.</a></li><li><a class="nounderline abstract_t">Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol 2009; 44:503.</a></li><li><a class="nounderline abstract_t">Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013; 62:1771.</a></li><li><a class="nounderline abstract_t">Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134:706.</a></li><li><a class="nounderline abstract_t">Takuma K, Kamisawa T, Igarashi Y. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol 2011; 23:80.</a></li><li><a class="nounderline abstract_t">Kamisawa T, Nakazawa T, Tazuma S, et al. Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2019; 26:9.</a></li><li><a class="nounderline abstract_t">Hamano H, Arakura N, Muraki T, et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41:1197.</a></li><li><a class="nounderline abstract_t">Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 2010; 34:1812.</a></li><li><a class="nounderline abstract_t">Saegusa H, Momose M, Kawa S, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas 2003; 27:20.</a></li><li><a class="nounderline abstract_t">Cheuk W, Yuen HK, Chu SY, et al. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32:671.</a></li><li><a class="nounderline abstract_t">Geyer JT, Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol 2011; 23:95.</a></li><li><a class="nounderline abstract_t">Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009; 68:1310.</a></li><li><a class="nounderline abstract_t">Kubota K, Wada T, Kato S, et al. Highly active state of autoimmune pancreatitis with mikulicz disease. Pancreas 2010; 39:e6.</a></li><li><a class="nounderline abstract_t">Li W, Xie XY, Su JZ, et al. Ultrasonographic Features of Immunoglobulin G4-Related Sialadenitis. Ultrasound Med Biol 2016; 42:167.</a></li><li><a class="nounderline abstract_t">De Cocker LJ, D'Arco F, De Beule T, et al. IgG4-related systemic disease affecting the parotid and submandibular glands: magnetic resonance imaging features of IgG4-related chronic sclerosing sialadenitis and concomitant lymphadenitis. Clin Imaging 2014; 38:195.</a></li><li><a class="nounderline abstract_t">Baldini C, Luciano N, Tarantini G, et al. Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome. Arthritis Res Ther 2015; 17:146.</a></li><li><a class="nounderline abstract_t">Ebbo M, Patient M, Grados A, et al. Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series. Medicine (Baltimore) 2017; 96:e6205.</a></li><li><a class="nounderline abstract_t">Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum 2014; 43:806.</a></li><li><a class="nounderline abstract_t">Wu A, Andrew NH, McNab AA, Selva D. IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review. Curr Allergy Asthma Rep 2015; 15:27.</a></li><li><a class="nounderline abstract_t">Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol 2015; 99:376.</a></li><li><a class="nounderline abstract_t">Mehta M, Jakobiec F, Fay A. Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglobulin G4-positive plasma cells. Arch Pathol Lab Med 2009; 133:1251.</a></li><li><a class="nounderline abstract_t">Wallace ZS, Khosroshahi A, Jakobiec FA, et al. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012; 57:26.</a></li><li><a class="nounderline abstract_t">Takahashi N, Ghazale AH, Smyrk TC, et al. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas 2009; 38:523.</a></li><li><a class="nounderline abstract_t">Ochoa ER, Harris NL, Pilch BZ. Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Küttner tumor). Am J Surg Pathol 2001; 25:1546.</a></li><li><a class="nounderline abstract_t">Sato Y, Takata K, Ichimura K, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol 2008; 88:428.</a></li><li><a class="nounderline abstract_t">Wallace ZS, Wallace CJ, Lu N, et al. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol 2016; 68:2283.</a></li><li><a class="nounderline abstract_t">Yu T, Wu Y, Liu J, et al. The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis. Arthritis Res Ther 2022; 24:14.</a></li><li><a class="nounderline abstract_t">Tiegs-Heiden CA, Eckel LJ, Hunt CH, et al. Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients. AJNR Am J Neuroradiol 2014; 35:1393.</a></li><li><a class="nounderline abstract_t">Chen TS, Montgomery EA. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol 2008; 61:1093.</a></li><li><a class="nounderline abstract_t">Taniguchi T, Kobayashi H, Fukui S, et al. A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4. Hum Pathol 2006; 37:1237.</a></li><li><a class="nounderline abstract_t">Hamed G, Tsushima K, Yasuo M, et al. Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis. Respirology 2007; 12:455.</a></li><li><a class="nounderline abstract_t">Nikiphorou E, Galloway J, Fragoulis GE. Overview of IgG4-related aortitis and periaortitis. A decade since their first description. Autoimmun Rev 2020; 19:102694.</a></li><li><a class="nounderline abstract_t">Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis 2016; 19:1049.</a></li><li><a class="nounderline abstract_t">Koo BS, Koh YW, Hong S, et al. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol 2015; 25:194.</a></li><li><a class="nounderline abstract_t">Zampeli E, Venetsanopoulou AI, Christaki S, et al. Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature. Clin Exp Rheumatol 2022; 40:1642.</a></li><li><a class="nounderline abstract_t">Kasashima F, Kawakami K, Matsumoto Y, et al. IgG4-Related Arterial Disease. Ann Vasc Dis 2018; 11:72.</a></li><li><a class="nounderline abstract_t">Perugino CA, Wallace ZS, Meyersohn N, et al. Large vessel involvement by IgG4-related disease. Medicine (Baltimore) 2016; 95:e3344.</a></li><li><a class="nounderline abstract_t">Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 2015; 94:e680.</a></li><li><a class="nounderline abstract_t">Peng L, Zhang P, Li J, et al. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther 2020; 22:103.</a></li><li><a class="nounderline abstract_t">Fragoulis GE, Evangelatos G, Tektonidou MG. Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature. Clin Rheumatol 2021; 40:1167.</a></li><li><a class="nounderline abstract_t">Ozawa M, Fujinaga Y, Asano J, et al. Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther 2017; 19:223.</a></li><li><a class="nounderline abstract_t">Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23:88.</a></li><li><a class="nounderline abstract_t">Stone JH, Khosroshahi A, Deshpande V, Stone JR. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken) 2010; 62:316.</a></li><li><a class="nounderline abstract_t">Kasashima S, Zen Y, Kawashima A, et al. A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta. J Vasc Surg 2010; 52:1587.</a></li><li><a class="nounderline abstract_t">Katz G, Hedgire SH, Stone JR, et al. IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement. Semin Arthritis Rheum 2023; 60:152184.</a></li><li><a class="nounderline abstract_t">Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 2011; 261:625.</a></li><li><a class="nounderline abstract_t">Falhammar H, Juhlin CC, Barner C, et al. Riedel's thyroiditis: clinical presentation, treatment and outcomes. Endocrine 2018; 60:185.</a></li><li><a class="nounderline abstract_t">Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009; 33:1886.</a></li><li><a class="nounderline abstract_t">Inoue D, Zen Y, Abo H, et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 2009; 251:260.</a></li><li><a class="nounderline abstract_t">Fujinaga Y, Kadoya M, Kawa S, et al. Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 2010; 76:228.</a></li><li><a class="nounderline abstract_t">Inoue M, Nose N, Nishikawa H, et al. Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovasc Surg 2007; 55:431.</a></li><li><a class="nounderline abstract_t">Ito M, Yasuo M, Yamamoto H, et al. Central airway stenosis in a patient with autoimmune pancreatitis. Eur Respir J 2009; 33:680.</a></li><li><a class="nounderline abstract_t">Yamamoto H, Yasuo M, Nomura Y, et al. IgG4-related airway involvement which developed in a patient receiving corticosteroid therapy for autoimmune pancreatitis. Intern Med 2011; 50:3023.</a></li><li><a class="nounderline abstract_t">Rudmik L, Trpkov K, Nash C, et al. Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ 2006; 175:367.</a></li><li><a class="nounderline abstract_t">Murashima M, Tomaszewski J, Glickman JD. Chronic tubulointerstitial nephritis presenting as multiple renal nodules and pancreatic insufficiency. Am J Kidney Dis 2007; 49:e7.</a></li><li><a class="nounderline abstract_t">Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol 2006; 30:1472.</a></li><li><a class="nounderline abstract_t">Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010; 78:1016.</a></li><li><a class="nounderline abstract_t">Chaba A, Devresse A, Audard V, et al. Clinical and Prognostic Factors in Patients with IgG4-Related Kidney Disease. Clin J Am Soc Nephrol 2023; 18:1031.</a></li><li><a class="nounderline abstract_t">Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 2013; 83:455.</a></li><li><a class="nounderline abstract_t">Stone JH. IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int 2013; 83:348.</a></li><li><a class="nounderline abstract_t">Cheuk W, Lee KC, Chong LY, et al. IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol 2009; 33:1713.</a></li><li><a class="nounderline abstract_t">Miyagawa-Hayashino A, Matsumura Y, Kawakami F, et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease? Hum Pathol 2009; 40:1269.</a></li><li><a class="nounderline abstract_t">Ikeda T, Oka M, Shimizu H, et al. IgG4-related skin manifestations in patients with IgG4-related disease. Eur J Dermatol 2013; 23:241.</a></li><li><a class="nounderline abstract_t">Charrow A, Imadojemu S, Stephen S, et al. Cutaneous manifestations of IgG4-related disease (RD): A systematic review. J Am Acad Dermatol 2016; 75:197.</a></li><li><a class="nounderline abstract_t">Umemura T, Zen Y, Hamano H, et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 2007; 56:1471.</a></li><li><a class="nounderline abstract_t">Zen Y, Fujii T, Sato Y, et al. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 2007; 20:884.</a></li><li><a class="nounderline abstract_t">Uehara T, Hamano H, Kawa S, et al. Chronic gastritis in the setting of autoimmune pancreatitis. Am J Surg Pathol 2010; 34:1241.</a></li><li><a class="nounderline abstract_t">Cheuk W, Chan AC, Lam WL, et al. IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases. Am J Surg Pathol 2009; 33:1058.</a></li><li><a class="nounderline abstract_t">Zen Y, Kasahara Y, Horita K, et al. Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis. Am J Surg Pathol 2005; 29:275.</a></li><li><a class="nounderline abstract_t">Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 2009; 56:1033.</a></li><li><a class="nounderline abstract_t">Haraguchi A, Era A, Yasui J, et al. Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J 2010; 57:719.</a></li><li><a class="nounderline abstract_t">Joshi D, Jager R, Hurel S, et al. Cerebral involvement in IgG4-related disease. Clin Med (Lond) 2015; 15:130.</a></li><li><a class="nounderline abstract_t">Uehara T, Hamano H, Kawakami M, et al. Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 2008; 58:118.</a></li><li><a class="nounderline abstract_t">Sekulic M, Pichler Sekulic S, Movahedi-Lankarani S. IgG4-related Disease of the Ovary: A First Description. Int J Gynecol Pathol 2017; 36:190.</a></li><li><a class="nounderline abstract_t">Sugimoto T, Morita Y, Isshiki K, et al. Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease. Int J Cardiol 2008; 130:e100.</a></li><li><a class="nounderline abstract_t">Takikita-Suzuki M, Ishida M, Okabe H. Re-evaluation of IgG4 in systemic fibroinflammatory disease with intracardiac involvement. Hum Pathol 2010; 41:458.</a></li><li><a class="nounderline abstract_t">Fatemi G, Fang MA. IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al. Arthritis Rheum 2013; 65:2217.</a></li><li><a class="nounderline abstract_t">Carruthers MN, Miloslavsky EM, Stone JH. Reply: To PMID 22736240. Arthritis Rheum 2013; 65:2217.</a></li><li><a class="nounderline abstract_t">Della-Torre E, Mattoo H, Mahajan VS, et al. IgG4-related midline destructive lesion. Ann Rheum Dis 2014; 73:1434.</a></li><li><a class="nounderline abstract_t">Karim F, Clahsen-van Groningen M, van Laar JA. AA Amyloidosis and IgG4-Related Disease. N Engl J Med 2017; 376:599.</a></li><li><a class="nounderline abstract_t">Fudim M, Thorpe MP, Chang LL, et al. Cardiovascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Fibroinflammatory Disorders. JACC Cardiovasc Imaging 2018; 11:365.</a></li><li><a class="nounderline abstract_t">de la Fuente J, Bird J. Coronary Arteritis in IgG4-Related Disease. N Engl J Med 2019; 380:2156.</a></li><li><a class="nounderline abstract_t">Ruggio A, Iaconelli A, Panaioli E, et al. Coronary Artery Aneurysms Presenting as Acute Coronary Syndrome: An Unusual Case of IgG4-Related Disease Vascular Involvement. Can J Cardiol 2018; 34:1088.e7.</a></li><li><a class="nounderline abstract_t">Morf H, Roemer F, Agaimy A, et al. IgG4-related fasciitis. Rheumatology (Oxford) 2021; 61:e11.</a></li><li><a class="nounderline abstract_t">Baker MC, Cook C, Fu X, et al. The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease. J Rheumatol 2023; 50:408.</a></li><li><a class="nounderline abstract_t">Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015; 74:14.</a></li><li><a class="nounderline abstract_t">Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007; 5:1229.</a></li><li><a class="nounderline abstract_t">Khosroshahi A, Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol 2014; 66:213.</a></li><li><a class="nounderline abstract_t">Peng L, Lu H, Zhou J, et al. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study. Arthritis Res Ther 2021; 23:102.</a></li><li><a class="nounderline abstract_t">Fujita Y, Fukui S, Umeda M, et al. Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia. Front Immunol 2022; 13:828122.</a></li><li><a class="nounderline abstract_t">Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica 2019; 104:444.</a></li><li><a class="nounderline abstract_t">Liu Y, Yang F, Chi X, et al. Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease. Arthritis Res Ther 2021; 23:54.</a></li><li><a class="nounderline abstract_t">Moriyama M, Furukawa S, Kawano S, et al. The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Int J Oral Maxillofac Surg 2014; 43:1276.</a></li><li><a class="nounderline abstract_t">Moriyama M, Ohta M, Furukawa S, et al. The diagnostic utility of labial salivary gland biopsy in IgG4-related disease. Mod Rheumatol 2016; 26:725.</a></li><li><a class="nounderline abstract_t">Khosroshahi A, Wallace ZS, Crowe JL, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol 2015; 67:1688.</a></li><li><a class="nounderline abstract_t">Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010; 37:1380.</a></li><li><a class="nounderline abstract_t">Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25:1181.</a></li><li><a class="nounderline abstract_t">Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 2009; 22:589.</a></li><li><a class="nounderline abstract_t">Sato Y, Kojima M, Takata K, et al. Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol 2010; 63:1084.</a></li><li><a class="nounderline abstract_t">Sato Y, Inoue D, Asano N, et al. Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes. Mod Pathol 2012; 25:956.</a></li><li><a class="nounderline abstract_t">Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol 2011; 23:74.</a></li><li><a class="nounderline abstract_t">Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 2020; 79:77.</a></li><li><a class="nounderline abstract_t">Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009; 39:469.</a></li><li><a class="nounderline abstract_t">Liu LJ, Chen M, Yu F, et al. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Nephrology (Carlton) 2008; 13:629.</a></li><li><a class="nounderline abstract_t">Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102:1646.</a></li><li><a class="nounderline abstract_t">Cao Z, Tian R, Zhang T, Zhao Y. Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review. Medicine (Baltimore) 2015; 94:e1656.</a></li><li><a class="nounderline abstract_t">Sun L, Zhou Q, Brigstock DR, et al. Focal autoimmune pancreatitis and chronic sclerosing sialadenitis mimicking pancreatic cancer and neck metastasis. World J Gastroenterol 2014; 20:17674.</a></li><li><a class="nounderline abstract_t">Goodchild G, Pereira SP, Webster G. Immunoglobulin G4-related sclerosing cholangitis. Korean J Intern Med 2018; 33:841.</a></li><li><a class="nounderline abstract_t">Björnsson E. Immunoglobulin G4-associated cholangitis. Curr Opin Gastroenterol 2008; 24:389.</a></li><li><a class="nounderline abstract_t">Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis--overlapping or separate diseases? J Hepatol 2009; 51:398.</a></li><li><a class="nounderline abstract_t">Moon SH, Kim MH, Lee JK, et al. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. J Gastroenterol 2017; 52:483.</a></li><li><a class="nounderline abstract_t">Tabata T, Kamisawa T, Hara S, et al. Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma. Gut Liver 2013; 7:234.</a></li><li><a class="nounderline abstract_t">Neild GH, Rodriguez-Justo M, Wall C, Connolly JO. Hyper-IgG4 disease: report and characterisation of a new disease. BMC Med 2006; 4:23.</a></li><li><a class="nounderline abstract_t">Zen Y, Onodera M, Inoue D, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009; 33:1833.</a></li><li><a class="nounderline abstract_t">Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359:1403.</a></li><li><a class="nounderline abstract_t">Khosroshahi A, Carruthers MN, Stone JH, et al. Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 2013; 92:82.</a></li><li><a class="nounderline abstract_t">Fragoulis GE, Zampeli E, Moutsopoulos HM. IgG4-related sialadenitis and Sjögren's syndrome. Oral Dis 2017; 23:152.</a></li><li><a class="nounderline abstract_t">Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 2011; 23:18.</a></li><li><a class="nounderline abstract_t">Koo BS, Koh YW, Hong S, et al. Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises. Int J Rheum Dis 2014; 17:420.</a></li><li><a class="nounderline abstract_t">Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol 2009; 23:339.</a></li><li><a class="nounderline abstract_t">Stone JR, Bruneval P, Angelini A, et al. Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. Cardiovasc Pathol 2015; 24:267.</a></li><li><a class="nounderline abstract_t">Mavragani CP, Fragoulis GE, Rontogianni D, et al. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease? Arthritis Care Res (Hoboken) 2014; 66:773.</a></li><li><a class="nounderline abstract_t">Smerla RG, Rontogianni D, Fragoulis GE. Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report. Clin Rheumatol 2018; 37:1721.</a></li><li><a class="nounderline abstract_t">Corcoran JP, Culver EL, Anstey RM, et al. Thoracic involvement in IgG4-related disease in a UK-based patient cohort. Respir Med 2017; 132:117.</a></li><li><a class="nounderline abstract_t">Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS 2018; 126:459.</a></li><li><a class="nounderline abstract_t">Tsushima K, Yokoyama T, Kawa S, et al. Elevated IgG4 levels in patients demonstrating sarcoidosis-like radiologic findings. Medicine (Baltimore) 2011; 90:194.</a></li><li><a class="nounderline abstract_t">Tsushima K, Tanabe T, Yamamoto H, et al. Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest 2009; 39:714.</a></li><li><a class="nounderline abstract_t">Li Y, Bai Y, Liu Z, et al. Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int 2009; 59:636.</a></li><li><a class="nounderline abstract_t">Stan MN, Sonawane V, Sebo TJ, et al. Riedel's thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf) 2017; 86:425.</a></li><li><a class="nounderline abstract_t">Li Y, Nishihara E, Kakudo K. Hashimoto's thyroiditis: old concepts and new insights. Curr Opin Rheumatol 2011; 23:102.</a></li><li><a class="nounderline abstract_t">Zhang P, Cornell LD. IgG4-Related Tubulointerstitial Nephritis. Adv Chronic Kidney Dis 2017; 24:94.</a></li><li><a class="nounderline abstract_t">Danlos FX, Rossi GM, Blockmans D, et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome. Autoimmun Rev 2017; 16:1036.</a></li><li><a class="nounderline abstract_t">Della-Torre E, Lanzillotta M, Campochiaro C, et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. Medicine (Baltimore) 2016; 95:e4633.</a></li><li><a class="nounderline abstract_t">Kawashima H, Utsugi A, Shibamiya A, et al. Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. Immunol Res 2019; 67:99.</a></li><li><a class="nounderline abstract_t">Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 2008; 32:197.</a></li><li><a class="nounderline abstract_t">Prucha M, Sedivy P, Stadler P, et al. Abdominal aortic aneurysm as an IgG4-related disease. Clin Exp Immunol 2019; 197:361.</a></li><li><a class="nounderline abstract_t">Caradu C, Ammollo RP, Dari L, et al. Management of Inflammatory Aortic Aneurysms - A Scoping Review. Eur J Vasc Endovasc Surg 2023; 65:493.</a></li><li><a class="nounderline abstract_t">Baskerville PA, Blakeney CG, Young AE, Browse NL. The diagnosis and treatment of peri-aortic fibrosis ('inflammatory' aneurysms). Br J Surg 1983; 70:381.</a></li></ol></div><div id="topicVersionRevision">Topic 121220 Version 11.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22316447" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25481618" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38229361" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Management of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14614606" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : A new clinicopathological entity of IgG4-related autoimmune disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124086" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A clinical overview of IgG4-related systemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21452084" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37137671" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25988916" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25151972" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The clinical spectrum of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20457280" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20733352" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20353791" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25047016" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Diagnosis and treatment of autoimmune pancreatitis types 1 and 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26085439" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical profiles and outcomes in idiopathic duct-centric chronic pancreatitis (type 2 autoimmune pancreatitis): the Mayo Clinic experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25770706" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Recent Advances in Autoimmune Pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17520216" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19377842" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Autoimmune pancreatitis in Japan: overview and perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23232048" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18222442" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124090" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30575336" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Clinical practice guidelines for IgG4-related sclerosing cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17287899" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21107087" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : IgG4-related disease: a cross-sectional study of 114 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12826901" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18344866" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Lymphadenopathy of IgG4-related sclerosing disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124091" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : IgG4-associated sialadenitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18701557" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19904224" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Highly active state of autoimmune pancreatitis with mikulicz disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26518180" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Ultrasonographic Features of Immunoglobulin G4-Related Sialadenitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24332556" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : IgG4-related systemic disease affecting the parotid and submandibular glands: magnetic resonance imaging features of IgG4-related chronic sclerosing sialadenitis and concomitant lymphadenitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26022533" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28272212" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24513111" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26141575" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25185258" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19653720" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Idiopathic fibroinflammatory disease of the face, eyelids, and periorbital membrane with immunoglobulin G4-positive plasma cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22018678" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19258916" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11717546" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Küttner tumor).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18839275" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : IgG4-producing marginal zone B-cell lymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27273903" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Association of IgG4-Related Disease With History of Malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34986892" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24627453" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18682417" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16938531" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A case of multifocal fibrosclerosis involving posterior mediastinal fibrosis, retroperitoneal fibrosis, and a left seminal vesicle with elevated serum IgG4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17539856" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Inflammatory lesions of the lung, submandibular gland, bile duct and prostate in a patient with IgG4-associated multifocal systemic fibrosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33121641" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Overview of IgG4-related aortitis and periaortitis. A decade since their first description.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27125330" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : IgG4-related retroperitoneal fibrosis: a newly characterized disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25036229" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34796838" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29682110" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : IgG4-Related Arterial Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27428181" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Large vessel involvement by IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25881845" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : IgG4-related disease: dataset of 235 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32366271" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32710295" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28978347" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21037477" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20391477" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20678882" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A clinicopathologic study of immunoglobulin G4-related sclerosing disease of the thoracic aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36848823" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : IgG4-related disease as a variable-vessel vasculitis: A case series of 13 patients with medium-sized coronary artery involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21803920" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29380231" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Riedel's thyroiditis: clinical presentation, treatment and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19898222" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19221056" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Immunoglobulin G4-related lung disease: CT findings with pathologic correlations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19581062" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18018609" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Successful treatment of sclerosing mediastinitis with a high serum IgG4 level.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19251805" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Central airway stenosis in a patient with autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22185997" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : IgG4-related airway involvement which developed in a patient receiving corticosteroid therapy for autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16908897" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17185138" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Chronic tubulointerstitial nephritis presenting as multiple renal nodules and pancreatic insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17063091" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Nephropathy in IgG4-related systemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20720530" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37283461" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Clinical and Prognostic Factors in Patients with IgG4-Related Kidney Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23254897" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Membranous glomerulonephritis is a manifestation of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23446252" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19701072" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : IgG4-related Sclerosing disease: a potential new etiology of cutaneous pseudolymphoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19386351" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23557874" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : IgG4-related skin manifestations in patients with IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26946983" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Cutaneous manifestations of IgG4-related disease (RD): A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17504944" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17571078" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20697253" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Chronic gastritis in the setting of autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19384187" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : IgG4-related sclerosing mastitis: description of a new member of the IgG4-related sclerosing diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15644785" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Inflammatory pseudotumor of the breast in a patient with a high serum IgG4 level: histologic similarity to sclerosing pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19926920" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20467161" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25824063" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Cerebral involvement in IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18199162" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27149005" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : IgG4-related Disease of the Ovary: A First Description.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17727980" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20159234" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Re-evaluation of IgG4 in systemic fibroinflammatory disease with intracardiac involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23666890" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23677887" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Reply: To PMID 22736240.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24651619" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : IgG4-related midline destructive lesion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28177871" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : AA Amyloidosis and IgG4-Related Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29413443" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Cardiovascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Fibroinflammatory Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31141636" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Coronary Arteritis in IgG4-Related Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30056847" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Coronary Artery Aneurysms Presenting as Acute Coronary Syndrome: An Unusual Case of IgG4-Related Disease Vascular Involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34459882" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : IgG4-related fasciitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36319016" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24651618" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : The diagnostic utility of serum IgG4 concentrations in IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17702660" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24431286" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33827676" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35296071" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30705099" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : IgG4-related disease: what a hematologist needs to know.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33568210" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25062551" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : The diagnostic utility of biopsies from the submandibular and labial salivary glands in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26873153" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : The diagnostic utility of labial salivary gland biopsy in IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25809420" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20436071" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22596100" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Consensus statement on the pathology of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19270642" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20974624" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22481280" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124089" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Pathological features of IgG4-related sclerosing disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31796497" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19222496" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Immunoglobulin G4: an odd antibody.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18775059" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17555461" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26496272" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Localized Autoimmune Pancreatitis: Report of a Case Clinically Mimicking Pancreatic Cancer and a Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25516685" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Focal autoimmune pancreatitis and chronic sclerosing sialadenitis mimicking pancreatic cancer and neck metastasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30045615" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Immunoglobulin G4-related sclerosing cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18408470" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Immunoglobulin G4-associated cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19505739" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis--overlapping or separate diseases?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27470434" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23560161" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17026742" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Hyper-IgG4 disease: report and characterisation of a new disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19950407" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11978339" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23429355" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Rethinking Ormond's disease: "idiopathic" retroperitoneal fibrosis in the era of IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27318181" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : IgG4-related sialadenitis and Sjögren's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124083" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : IgG4-related inflammatory abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24447903" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19508942" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Chronic periaortitis: a fibro-inflammatory disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26051917" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25100215" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29204759" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29229083" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Thoracic involvement in IgG4-related disease in a UK-based patient cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29924455" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21512409" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Elevated IgG4 levels in patients demonstrating sarcoidosis-like radiologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19496802" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Pulmonary involvement of autoimmune pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19712131" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27647429" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Riedel's thyroiditis association with IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124092" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Hashimoto's thyroiditis: old concepts and new insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28284385" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : IgG4-Related Tubulointerstitial Nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28780079" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27559962" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30734199" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18223321" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31032886" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Abdominal aortic aneurysm as an IgG4-related disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36623764" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Management of Inflammatory Aortic Aneurysms - A Scoping Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6860915" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : The diagnosis and treatment of peri-aortic fibrosis ('inflammatory' aneurysms).</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
